By Johnathan George | Posted: 31 August 2015
Today’s kick-off of the OSA’s second Photobiomodulation (PBM) Incubator brings together scientists, practitioners, and industry to discuss the latest research, future, and hurdles for PBM’s acceptance as a mainstream medical therapy.
The day began with hosts Michael Hamblin Ph.D. and Donald Patthoff DDS introducing the goal of the Incubator: to come together to bring a coherent message about the scientific validity and potential for PBM. They said there will be an expectation of no spectators and an “all hands on deck” attitude at the Incubator, where all attendees are expected to participate.
Read the full post